Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,697 Million (Mid Cap)
47.00
NA
0.31%
-0.32
12.56%
5.54
Revenue and Profits:
Net Sales:
394 Million
(Quarterly Results - Sep 2025)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.85%
0%
-23.85%
6 Months
-11.91%
0%
-11.91%
1 Year
183.38%
0%
183.38%
2 Years
65.59%
0%
65.59%
3 Years
62.62%
0%
62.62%
4 Years
100.4%
0%
100.4%
5 Years
200.6%
0%
200.6%
Doctorglasses Chain Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.22%
EBIT Growth (5y)
22.07%
EBIT to Interest (avg)
17.52
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.29
Tax Ratio
21.29%
Dividend Payout Ratio
45.68%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.66%
ROE (avg)
13.77%
Valuation key factors
Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
6.03
EV to EBIT
36.38
EV to EBITDA
16.03
EV to Capital Employed
10.77
EV to Sales
3.52
PEG Ratio
NA
Dividend Yield
0.73%
ROCE (Latest)
29.60%
ROE (Latest)
12.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
394.10
360.20
9.41%
Operating Profit (PBDIT) excl Other Income
39.70
69.20
-42.63%
Interest
1.60
2.00
-20.00%
Exceptional Items
0.70
2.20
-68.18%
Consolidate Net Profit
33.20
27.30
21.61%
Operating Profit Margin (Excl OI)
100.80%
86.30%
1.45%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.41% vs 10.42% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 21.61% vs -12.22% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,198.70
1,171.60
2.31%
Operating Profit (PBDIT) excl Other Income
294.80
326.60
-9.74%
Interest
12.80
11.60
10.34%
Exceptional Items
-13.30
0.30
-4,533.33%
Consolidate Net Profit
101.30
131.80
-23.14%
Operating Profit Margin (Excl OI)
111.90%
136.90%
-2.50%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.31% vs 22.05% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -23.14% vs 77.15% in Dec 2023
About Doctorglasses Chain Co., Ltd. 
Doctorglasses Chain Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






